menu
    • menu

    Company profile for Quagen Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Quagen Pharmaceuticals has roughly 78 employees with senior management accounting for over 75 years of combined experience in Regulatory, Quality, Manufacturing and Sales.Quagen Pharma is led by Ashish Shah R.Ph., President/CEO who has over 25 years of experience in Pharmaceutical Manufacturing and Marketing.Quagen Pharma is an integrated, pharmaceutical company developing to produce a wide range of quality, affordable generic...
    Quagen Pharmaceuticals has roughly 78 employees with senior management accounting for over 75 years of combined experience in Regulatory, Quality, Manufacturing and Sales.Quagen Pharma is led by Ashish Shah R.Ph., President/CEO who has over 25 years of experience in Pharmaceutical Manufacturing and Marketing.Quagen Pharma is an integrated, pharmaceutical company developing to produce a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Quagen PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11 Patton Drive West Caldwell, NJ 07006
    Telephone
    Telephone
    (973)-228-9600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.quagenpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Quagen’s Generics Aripiprazole Receives Approval in US
    Quagen’s Generics Aripiprazole Receives Approval in US

    22 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215582

    FDA
    22 Oct 2025
    Share Share
    Quagen's Generic Glycopyrrolate Receives Approval in the U.S.
    Quagen's Generic Glycopyrrolate Receives Approval in the U.S.

    10 Jul 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212696

    FDA
    10 Jul 2024
    Share Share
    Quagen's Generic Butalbital, Acetaminophen and Caffeine Receives Approval in the U.S.
    Quagen's Generic Butalbital, Acetaminophen and Caffeine Receives Approval in the U.S.

    12 Mar 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216376

    FDA
    12 Mar 2024
    Share Share
    Quagen's Generic Butalbital and Acetaminophen Receives Approval in the U.S.
    Quagen's Generic Butalbital and Acetaminophen Receives Approval in the U.S.

    01 Feb 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214305

    FDA
    01 Feb 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search